Dr. Keith T Tracy, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 780 Main St, S Weymouth, MA 02190 Phone: 781-331-4600 Fax: 781-337-5095 |
News Archive
According to the Australasian College of Cosmetic Surgery all brands of breast implants carry a risk of rupture. Spokesman Dr Daniel Fleming said a rupture rate of 13.6 per cent over eight years is a normal rate for major brand Mentor.
The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors (CGM) show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors - six days per week or more - rather than the age of patients, and that benefits continue well past the time when people with type 1 diabetes begin using the devices - including experiencing fewer low blood sugar emergencies.
Inovio Pharmaceuticals, Inc. announced today it has received a U.S. Department of Defense Small Business Innovation Research Grant to advance the development of a low-cost, non-invasive surface electroporation (EP) delivery device and test its utility in combination with Inovio's novel synthetic DNA vaccines against viruses with bioterrorism potential, including hanta, puumala, arenavirus and pandemic influenza.
Healthpoint today announced that the U.S. Food and Drug Administration has granted approval to manufacture commercial supplies of Collagenase SANTYL Ointment, a biologic enzymatic debriding agent, at DPT Laboratories' Center of Excellence for Sterile & Specialty Products facility in Lakewood, New Jersey.
› Verified 2 days ago